|
Medical News -
Complementary and Alternative Medicine
|
|
Caleco Pharma Corp. (the "Company") (OTCBB:CAEH)(FRANKFURT:T3R)(WKN:AON9YO) is pleased to announce that, in collaboration with Puleva Biotech S.A. ("Biotech"), a publicly listed Spanish Corporation engaged in the business of research, development and commercialization of health related products, it is initiating a clinical study to evaluate the effectiveness of "Lamiridosin", a dietary supplement that the Company is in the process of developing. Read more:
|
